Literature DB >> 9002445

Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes.

A Kondo1, J Sidney, S Southwood, M F del Guercio, E Appella, H Sakamoto, H M Grey, E Celis, R W Chesnut, R T Kubo, A Sette.   

Abstract

Previous studies have defined two different peptide binding motifs specific for HLA-A*0101. These motifs are characterized by the presence of tyrosine (Y) at the C-termini of 9-mer and 10-mer peptides, and either a small polar or hydrophobic (S, T, M) residue in position 2, or a negatively charged (D or E) residue in position 3. In this study, the structural requirements for peptide binding to A*0101 have been further analyzed by examining the binding capacity of large sets of peptides corresponding to naturally occurring sequences which bore one or the other of these two A*0101-specific motifs. By correlating the presence of specific residue types at each position along the peptide sequence with increased (or decreased) binding affinity, the prominent influence of secondary anchor residues was revealed. In most cases, the two anchors in positions 2 and 3 appear to act synergistically. With the exception of the DE3 submotif in 9-mer peptides, a positive role for aromatic residues in position 1 and the center of the peptide (positions 4 or 5 of 9- or 10-mer peptides, respectively), and proline at C-3, were also consistently detected. However, secondary anchor residues also appear to differ significantly between the two different submotifs, demonstrating that A*0101 can utilize alternative modes in binding its peptide ligands. According to these analyses, specific refined submotifs were also established, and their merit verified by independent sets of potential A*0101 binding peptides. Besides providing useful insight into the nature of the interaction of the A*0101 allele with its peptide ligands, such refined motifs should also facilitate accurate prediction of potential A*0101-restricted peptide epitopes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002445     DOI: 10.1007/s002510050200

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  13 in total

1.  HLA-A*01-restricted cytotoxic T-lymphocyte epitope from the Plasmodium falciparum circumsporozoite protein.

Authors:  A Kumar; S Kumar; T P Le; S Southwood; J Sidney; J Cohen; A Sette; S L Hoffman
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.

Authors:  O Schueler-Furman; Y Altuvia; A Sette; H Margalit
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.

Authors:  Huynh-Hoa Bui; John Sidney; Bjoern Peters; Muthuraman Sathiamurthy; Asabe Sinichi; Kelly-Anne Purton; Bianca R Mothé; Francis V Chisari; David I Watkins; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-03       Impact factor: 2.846

4.  Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.

Authors:  John Sidney; Scott Southwood; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-07-08       Impact factor: 2.846

5.  Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules.

Authors:  John Sidney; Shinichi Asabe; Bjoern Peters; Kelly-Anne Purton; Josan Chung; Timothy J Pencille; Robert Purcell; Christopher M Walker; Francis V Chisari; Alessandro Sette
Journal:  Immunogenetics       Date:  2006-06-22       Impact factor: 2.846

6.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

7.  Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles.

Authors:  Bianca R Mothé; Scott Southwood; John Sidney; A Michelle English; Amanda Wriston; Ilka Hoof; Jeffrey Shabanowitz; Donald F Hunt; Alessandro Sette
Journal:  Immunogenetics       Date:  2013-02-17       Impact factor: 2.846

8.  Crystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptides.

Authors:  Nianzhi Zhang; Jianxun Qi; Sijia Feng; Feng Gao; Jun Liu; Xiaocheng Pan; Rong Chen; Qirun Li; Zhaosan Chen; Xiaoying Li; Chun Xia; George F Gao
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

9.  Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.

Authors:  Eishiro Mizukoshi; Michelina Nascimbeni; Joshua B Blaustein; Kathleen Mihalik; Charles M Rice; T Jake Liang; Stephen M Feinstone; Barbara Rehermann
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.